Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Heal

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Neuroscience Letters|October 11, 2003
Noradrenaline clearance differs in the frontal cortex and hypothalamus: a dual-probe microdialysis study in freely-moving ratsSandrine M Géranton, David J Heal, S Clare Stanford
Neuropharmacology|February 21, 2004
5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354Sandrine M Géranton, David J Heal, S Clare Stanford
Neuropharmacology|October 4, 2014
CNS stimulantsDavid J Heal, Sharon L Smith, Jack E Henningfield
CNS Drug Reviews|July 12, 2005
KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disordersSharon L Smith, David J Heal, Keith F Martin
Journal of Psychopharmacology (Oxford, England)|April 17, 2025
Discriminating evidence - use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugsDavid J Heal, Sharon Lesley Smith, Jane Gosden, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Amphetamine, past and present--a pharmacological and clinical perspectiveDavid J Heal, Sharon L Smith, Jane Gosden, et al.
Journal of Psychopharmacology (Oxford, England)|January 2, 2023
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspectiveJack E Henningfield, Judy Ashworth, David J Heal, et al.
European Journal of Pharmacology|September 15, 2004
Pharmacological characterisation of the thermogenic effect of bupropionYong-Ling Liu, Ian P Connoley, David J Heal, et al.
Drug and Alcohol Dependence|May 2, 2012
Assessment of ropinirole as a reinforcer in rhesus monkeysKevin B Freeman, David J Heal, Andrew C McCreary, et al.
Journal of Psychopharmacology (Oxford, England)|January 25, 2019
Investigation of the reinforcing potential of samidorphan and naltrexone by fixed and progressive ratio intravenous self-administration testing in heroin-maintained ratsSharon L Smith, Reginald L Dean, Mark S Todtenkopf, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Neuroscience Letters|October 11, 2003
Noradrenaline clearance differs in the frontal cortex and hypothalamus: a dual-probe microdialysis study in freely-moving ratsSandrine M Géranton, David J Heal, S Clare Stanford
Neuropharmacology|February 21, 2004
5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354Sandrine M Géranton, David J Heal, S Clare Stanford
Neuropharmacology|October 4, 2014
CNS stimulantsDavid J Heal, Sharon L Smith, Jack E Henningfield
CNS Drug Reviews|July 12, 2005
KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disordersSharon L Smith, David J Heal, Keith F Martin
Journal of Psychopharmacology (Oxford, England)|April 17, 2025
Discriminating evidence - use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugsDavid J Heal, Sharon Lesley Smith, Jane Gosden, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Amphetamine, past and present--a pharmacological and clinical perspectiveDavid J Heal, Sharon L Smith, Jane Gosden, et al.
Journal of Psychopharmacology (Oxford, England)|January 2, 2023
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspectiveJack E Henningfield, Judy Ashworth, David J Heal, et al.
European Journal of Pharmacology|September 15, 2004
Pharmacological characterisation of the thermogenic effect of bupropionYong-Ling Liu, Ian P Connoley, David J Heal, et al.
Drug and Alcohol Dependence|May 2, 2012
Assessment of ropinirole as a reinforcer in rhesus monkeysKevin B Freeman, David J Heal, Andrew C McCreary, et al.
Journal of Psychopharmacology (Oxford, England)|January 25, 2019
Investigation of the reinforcing potential of samidorphan and naltrexone by fixed and progressive ratio intravenous self-administration testing in heroin-maintained ratsSharon L Smith, Reginald L Dean, Mark S Todtenkopf, et al.
Pageof 5